Results 211 to 220 of about 58,766 (263)
Some of the next articles are maybe not open access.
Clinics in Chest Medicine, 2021
Malignant pleural effusions have a significant burden on patients and the health care system. Diagnosis is typically via thoracentesis, although other times more invasive procedures are required. Management centers around relief of dyspnea and patient quality of life and can be done via serial thoracentesis, indwelling pleural catheter, or pleurodesis.
Christopher M, Kapp, Hans J, Lee
openaire +2 more sources
Malignant pleural effusions have a significant burden on patients and the health care system. Diagnosis is typically via thoracentesis, although other times more invasive procedures are required. Management centers around relief of dyspnea and patient quality of life and can be done via serial thoracentesis, indwelling pleural catheter, or pleurodesis.
Christopher M, Kapp, Hans J, Lee
openaire +2 more sources
Cancer Treatment Reviews, 1978
Recurrent malignant pleural effusion is a relatively common problem that often occurs many months before the terminal stages of a patient's malignant disease. Despite careful evaluation, it is often impossible to identify the exact physiologic cause of an effusion and difficult to identify a pragmatic course of therapy.
M A, Friedman, E, Slater
openaire +2 more sources
Recurrent malignant pleural effusion is a relatively common problem that often occurs many months before the terminal stages of a patient's malignant disease. Despite careful evaluation, it is often impossible to identify the exact physiologic cause of an effusion and difficult to identify a pragmatic course of therapy.
M A, Friedman, E, Slater
openaire +2 more sources
Postgraduate Medicine, 1986
Pleural effusions are common in cancer patients, developing either from the malignant condition or from unrelated causes, such as congestive heart failure, pulmonary infarction, or infection. Diagnosis of malignant pleural effusion rests on demonstration of the presence of malignant cells in the pleural fluid or pleural biopsy specimen.
openaire +2 more sources
Pleural effusions are common in cancer patients, developing either from the malignant condition or from unrelated causes, such as congestive heart failure, pulmonary infarction, or infection. Diagnosis of malignant pleural effusion rests on demonstration of the presence of malignant cells in the pleural fluid or pleural biopsy specimen.
openaire +2 more sources
Management of Malignant Pleural Effusions
Drugs, 1998Malignant pleural effusions (MPEs) represent a common complication of advanced malignancies. However, adequate palliation of this highly symptomatic accompaniment to cancer can be achieved in most patients by adopting the appropriate therapy. Several options are available for the treatment of MPE.
Grossi F +4 more
openaire +2 more sources
2004
The presence of pleural effusions is a common clinical problem in patients with neoplastic disease. At the time of diagnosis, approximately 15% of lung cancer patients have a pleural effusion (Naito et al. 1997).Twenty to 50% of patients with advanced or disseminated lung cancer develop a pleural effusion during the course of the ir disease (Emerson et
Van Schil, P., Germonpré, P.
openaire +2 more sources
The presence of pleural effusions is a common clinical problem in patients with neoplastic disease. At the time of diagnosis, approximately 15% of lung cancer patients have a pleural effusion (Naito et al. 1997).Twenty to 50% of patients with advanced or disseminated lung cancer develop a pleural effusion during the course of the ir disease (Emerson et
Van Schil, P., Germonpré, P.
openaire +2 more sources
Management of malignant pleural effusions
Current Opinion in Internal Medicine, 2005Although malignant pleural effusions are a common medical problem, research into their optimal management remains sparse. The aim of this review is to summarise recent developments in this area.Talc remains the most efficacious pleurodesis agent.
Rachel, Bennett, Nick, Maskell
openaire +2 more sources
The treatment of malignant pleural effusions
Cancer, 1974This report reviews a 5-year experience in the treatment of malignant pleural effusion with particular emphasis on the use of closed-tube thoracostomy drainage with nitrogen mustard instillation. Of the 133 patients treated at the Barnes Hospital for malignant pleural effusion between January 1 1964 and December 31 1968 bilateral effusions were ...
C B, Anderson +2 more
openaire +2 more sources
Seminars in Respiratory and Critical Care Medicine, 1985
Various diseases of the gastrointestinal tract at times are accompanied by an exudative pleural effusion. The exudative pleural effusions resulting from esophageal perforation, pancreatic disease, subphrenic abscess, intrahepatic abscess, splenic abscess, abdominal operations, and diaphragmatic hernia are discussed in this article.
openaire +3 more sources
Various diseases of the gastrointestinal tract at times are accompanied by an exudative pleural effusion. The exudative pleural effusions resulting from esophageal perforation, pancreatic disease, subphrenic abscess, intrahepatic abscess, splenic abscess, abdominal operations, and diaphragmatic hernia are discussed in this article.
openaire +3 more sources
Management of Malignant Pleural Effusions
Seminars in Respiratory and Critical Care Medicine, 2008Malignant pleural effusions (MPEs) are commonly seen as complications of advanced malignancy, especially in lung cancer and breast cancer. The management will depend on the performance status of the patient, severity of the symptoms, and the primary tumor's response to systemic therapy.
Marcelo, Spector, Jeffrey S, Pollak
openaire +2 more sources
Management of Malignant Pleural Effusion
Lung, 2013Malignancy is one of the most common causes of pleural effusion. Malignant pleural effusion is defined by the presence of malignant cells in the pleural fluid. Development of malignant pleural effusion usually defines advanced malignancy. Pathophysiology of malignant pleural effusion is not fully understood and may involve complex interactions between ...
exaly +3 more sources

